ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,184.42
      -0.06%
      US Tech 100
      17,636.00
      0.13%
      Dow Jones
      38,943.26
      0.15%
      Brent Oil
      83.045
      0.22%
      Bitcoin
      62,251.85
      -0.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Prana Biotechnology Ltd ADS (PRAN)

      7. Prana Biotechnology Ltd ADS (PRAN) News

      PRAN

      Prana Biotechnology Ltd ADS (PRAN)

      Prana Biotechnology Ltd ADS
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PRAN
      DateTimeSourceHeadlineSymbolCompany
      1:05PMiHub NewswireFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      01/31/20199:01AMBusiness WirePrana Receives First Orphan Drug Designation from the FDA for the Treatment of Multiple System AtrophyNASDAQ:PRANPrana Biotechnology Ltd ADS
      01/02/20197:00AMPR Newswire (US)Life Biosciences LLC leads strategic investment of up to A$44.5 million (US$31.4 million) in PranaNASDAQ:PRANPrana Biotechnology Ltd ADS
      10/04/201811:47PMBusiness WirePrana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential Treatment for MSANASDAQ:PRANPrana Biotechnology Ltd ADS
      09/04/20186:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRANPrana Biotechnology Ltd ADS
      07/08/20188:15PMBusiness WirePBT434 Data to be Presented at the International Congress of Parkinson’s Disease and Movement DisordersNASDAQ:PRANPrana Biotechnology Ltd ADS
      07/03/20189:38PMBusiness WireFirst Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian DiseasesNASDAQ:PRANPrana Biotechnology Ltd ADS
      06/13/20188:55PMBusiness WirePrana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian DiseasesNASDAQ:PRANPrana Biotechnology Ltd ADS
      07/18/20179:00AMBusiness WirePrana Commences Research Collaboration with Takeda for the Treatment of Parkinson's Disease Gastrointestinal NeuropathologyNASDAQ:PRANPrana Biotechnology Ltd ADS
      07/05/20179:00AMBusiness WirePrana's PBT434 Lowers Alpha-Synuclein and Prevents NeurodegenerationNASDAQ:PRANPrana Biotechnology Ltd ADS
      06/05/20178:30AMBusiness WirePrana Appoints David Stamler as Chief Medical Officer to Lead Clinical DevelopmentNASDAQ:PRANPrana Biotechnology Ltd ADS
      10/18/201611:00AMBusiness WireNew Data from Reach2HD Trial Presented at American Neurological Association Annual MeetingNASDAQ:PRANPrana Biotechnology Ltd ADS
      07/27/201612:22PMBusiness WirePrana Alzheimer's disease data features at world leading conferenceNASDAQ:PRANPrana Biotechnology Ltd ADS
      04/11/20168:00AMBusiness WirePrana Regains Compliance with NASDAQ Continued Listing Requirements Continues to Work Towards FDA SubmissionNASDAQ:PRANPrana Biotechnology Ltd ADS
      02/26/20168:00AMBusiness WirePrana Biotechnology Half Year Investor ReportNASDAQ:PRANPrana Biotechnology Ltd ADS
      11/16/20159:00AMBusiness WirePrana Chief Scientific Advisor Receives Smithsonian American Ingenuity AwardNASDAQ:PRANPrana Biotechnology Ltd ADS
      11/09/20158:00AMBusiness WirePrana Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price RequirementNASDAQ:PRANPrana Biotechnology Ltd ADS
      08/27/20158:00AMBusiness WirePrana Reports FY15 Financial ResultsNASDAQ:PRANPrana Biotechnology Ltd ADS
      07/24/20159:00AMPR Newswire (US)Technical Report on Drug Manufacturers - Other Stocks -- Synergy Pharma, Teva Pharma, Orexigen Therapeutics, Prana Biotechnol...NASDAQ:PRANPrana Biotechnology Ltd ADS
      06/30/201511:58PMBusiness WirePrana Announces Safety Outcomes of Alzheimer’s IMAGINE Extension TrialNASDAQ:PRANPrana Biotechnology Ltd ADS
      06/01/20151:21PMBusiness WireLa Commission européenne approuve la désignation orpheline pour le PBT2 dans le cadre de la maladie de HuntingtonNASDAQ:PRANPrana Biotechnology Ltd ADS
      06/01/201511:20AMBusiness WireEuropäische Kommission gewährt PBT2 Orphan-Status für Chorea HuntingtonNASDAQ:PRANPrana Biotechnology Ltd ADS
      06/01/20159:00AMBusiness WireEuropean Commission Approves PBT2 Orphan Designation for Huntington’s DiseaseNASDAQ:PRANPrana Biotechnology Ltd ADS
      04/27/201511:22PMBusiness WirePBT2 Recommended for Orphan Designation in EuropeNASDAQ:PRANPrana Biotechnology Ltd ADS
      11/19/201411:00AMBusiness WireThe Lancet Neurology Publishes Prana's Huntington Disease TrialNASDAQ:PRANPrana Biotechnology Ltd ADS
      09/05/20149:49AMDow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNASDAQ:PRANPrana Biotechnology Ltd ADS
      09/05/20147:45AMPR Newswire (US)Prana receives FDA Orphan Drug Designation for PBT2 for Huntington DiseaseNASDAQ:PRANPrana Biotechnology Ltd ADS
      07/17/20144:10PMPR Newswire (US)Prana Alzheimer's disease Development Program updateNASDAQ:PRANPrana Biotechnology Ltd ADS
      05/16/20147:39AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRANPrana Biotechnology Ltd ADS
      05/14/20147:42AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRANPrana Biotechnology Ltd ADS
       Showing the most relevant articles for your search:NASDAQ:PRAN